EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
Hacker News·Sep 2·5 min read
The race to engineer new knobs for the human brain
TL;DR
Chemogenetics, a technique allowing remote control of specific neurons using designer drugs, is now in human clinical trials in China, potentially offering new treatments for conditions like epilepsy and Parkinson's disease.
✦ Why It Matters
Explore opportunities to collaborate on or invest in emerging chemogenetics research and trials.
Key Takeaways
- Investigate chemogenetics for targeted neurological therapies.
- Monitor ongoing clinical trials for insights into treatment efficacy.
- Consider implications of designer drugs in therapeutic applications.
- Stay informed about advancements in precision medicine technologies.
How It Works
Chemogenetics involves engineering neurons to express synthetic receptors that respond to specific designer drugs. For instance, DREADDs are modified human receptors that can be activated by clozapine, allowing for precise modulation of neuronal activity.
This targeted approach aims to inhibit or excite specific neurons, offering a more refined treatment for conditions like epilepsy.